REG - Rosebank Industries - Resuls of General Meeting and Open Offer

ROSEBANK INDUSTRIESAnnouncement

Tue 11:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250701:nRSA2341Pa&default-theme=true

RNS Number : 2341P  Rosebank Industries PLC  01 July 2025

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA (THE "UNITED STATES"
OR THE "US"), AUSTRALIA, CANADA, NEW ZEALAND, JAPAN, THE REPUBLIC OF SOUTH
AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR
DISTRIBUTION WOULD BE UNLAWFUL.

 

 

1 July 2025

 

Rosebank Industries plc

 

Results of General Meeting and Open Offer

 

Rosebank announces that at the General Meeting of the Company held today, all
resolutions put to Shareholders were duly passed. The table below shows the
results of the poll for each resolution.

 Resolution                                                                    For                Against        % of issued share capital voted  Votes withheld
                                                                               Number      %      Number   %
 1: To approve the acquisition of ECI Equity Holding Company Inc.              14,819,293  98.19  273,485  1.81  75.46%                           7,054
 2: To authorise the directors to allot shares in connection with the Capital  14,819,293  98.19  273,485  1.81  75.46%                           7,054
 Raise.
 3:  To authorise the limited disapplication of pre-emption rights in          14,807,210  98.11  285,452  1.89  75.46%                           7,170
 connection with the Capital Raise.
 4: To authorise the directors to allot shares post-Admission.                 15,090,652  99.99  1,731    0.01  75.46%                           7,449
 5: To authorise the limited disapplication of pre-emption rights              15,076,727  99.90  15,287   0.10  75.46%                           7,818
 post-Admission.
 6. To authorise the Company to buy back shares post-Admission.                15,090,730  99.99  1,987    0.01  75.46%                           7,115

 

1.   A "Vote withheld" is not a vote in law and is not counted in the
calculation of the percentage of shares voted "For" or "Against" any
resolution.

2.   The number of Ordinary Shares in issue at 6:30 p.m. on 27 June 2025 was
20,000,000 ("ISC"). Holders of Ordinary Shares are entitled to one vote per
share. No shares are held in treasury.

Open Offer

Rosebank also announces the results of the Open Offer launched on 11 June 2025
in connection with the Capital Raise. The Open Offer was oversubscribed, with
applications received in respect of 101% of the Open Offer Shares available,
which resulted in over 98% of applications being successful in full and the
balance being successful for all save for a small portion of their application
for the Excess Entitlement. As a result, 2,248,643 Open Offer Shares will be
issued in connection with the Open Offer, raising approximately £6.7 million
(before expenses) for the Company at an issue price of £3.00 per share.

Admission and dealings

Application has been made to the London Stock Exchange for the admission of
386,607,653 New Ordinary Shares, comprising 380,000,000 Placing Shares and US
Private Placement Shares, in aggregate, 4,359,010 Connected Persons Shares and
2,248,643 Open Offer Shares, to trading on AIM ("Admission"). Admission is
expected to take place and dealings in the New Ordinary Shares are expected to
commence on or around 8.00 a.m. on 3 July 2025.

Completion

Subject to the satisfaction or, where appropriate, waiver of the conditions to
the Acquisition, it is expected that completion of the Acquisition will occur
in the third quarter of 2025. On completion, in accordance with AIM Rule 14,
the admission of the Ordinary Shares will be cancelled and application will be
made for Readmission of the Enlarged Group.

 

 Enquiries for Rosebank:
 Rosebank                                                                   Via Montfort Communications
 Simon Peckham, Matthew Richards
 Montfort Communications                                                    +44 7739 701 634 / +44 7921 881 800
 Nick Miles, Charlotte McMullen
 Barclays Bank PLC                                                          +44 (0) 20 7623 2323
 (Financial Adviser and Joint Global Coordinator)
 Yuri Shakhmin, Chris Madderson, Callum West
 Citigroup Global Markets Limited                                           +44 (0) 20 7986 4000
 (Financial Adviser, Joint Global Coordinator and Joint Corporate Broker)
 Michael Lavelle, Greg Dalle, Patrick Evans
 Investec Bank plc                                                          +44 (0) 20 7597 5970
 (Nominated Adviser, Financial Adviser, Joint Global Coordinator and Joint
 Corporate Broker)
 Carlton Nelson, Christopher Baird, Duncan Smith

Capitalised terms used in this announcement have the meanings given to them in
the Company's announcement on 6 June 2025, unless the context provides
otherwise.

 

Important information

This announcement has been issued by, and is the sole responsibility of,
Rosebank Industries plc.

The information contained in this announcement is for background purposes only
and does not purport to be full or complete. No reliance may be placed for any
purpose whatsoever on the completeness, accuracy or fairness of the
information or opinions contained in this announcement.

Nothing in this announcement constitutes legal, financial, tax or other advice
or takes into account the particular investment objectives, financial
situation, taxation position or needs of any person.

This announcement is not for publication, release or distribution, directly or
indirectly, in whole or in part, in or into or from the United States,
Australia, Canada, New Zealand, Japan, the Republic of South Africa or any
other state or jurisdiction in which such publication, release or distribution
would be unlawful. This announcement and the information contained herein is
not intended to and does not contain or constitute an offer of, or the
solicitation of an offer to buy or subscribe for, securities to any person in
the United States, Australia, Canada, New Zealand, Japan, the Republic of
South Africa or any other state or jurisdiction in which such an offer would
be unlawful.

The distribution of this announcement may be restricted by law in certain
jurisdictions and persons into whose possession any document or other
information referred to herein comes should inform themselves about and
observe any such restriction. Any failure to comply with these restrictions
may constitute a violation of the securities laws of any such jurisdiction.

The New Ordinary Shares have not been and will not be registered under the US
Securities Act of 1933, as amended, and may not be offered or sold in the
United States, absent registration or an applicable exemption from
registration. The Company has no intention to register any part of the Capital
Raise in the United States or make a public offering of securities in the
United States.

Each of: (i) the Company; and (ii) Barclays Bank PLC ("Barclays"), BNP PARIBAS
("BNPP"), Citigroup Global Markets Limited ("Citigroup") and Investec Bank plc
("Investec") (together, the "Banks"), and in each case, their respective
affiliates as defined under Rule 501(b) of Regulation D under the Securities
Act ("affiliates"), expressly disclaims any obligation or undertaking to
update, review or revise any forward-looking statement contained in this
announcement whether as a result of new information, future developments or
otherwise.

No representation or warranty, express or implied, is made or given by or on
behalf of the Company, the Banks, or any of their respective parent or
subsidiary undertakings or the subsidiary undertakings of any such parent
undertakings, or any of such person's directors, officers, affiliates, agents,
advisers, employees, or any other person, as to the accuracy, completeness or
fairness of the information or opinions contained in this announcement and no
responsibility or liability is accepted for any such information or opinions.

Each of Investec, Barclays and Citigroup are authorised by the Prudential
Regulation Authority (the "PRA") and regulated in the UK by the PRA and the
Financial Conduct Authority (the "FCA"). BNPP is authorised and regulated by
the European Central Bank and the Autorité de contrôle prudentiel et de
résolution, and is authorised by the PRA and is subject to regulation by the
FCA and limited regulation by the PRA. Each Bank is acting exclusively for the
Company and no one else in connection with the Placing and Admission. They
will not regard any other person (whether or not a recipient of this
announcement) as their client in relation to the Placing and Admission and
will not be responsible to anyone other than the Company for providing the
protections afforded to their respective clients nor for giving advice in
relation to the Placing and Admission or any transaction or arrangement
referred to in this announcement.

 

Information to distributors

Solely for the purposes of the product governance requirements of Chapter 3 of
the FCA Handbook Product Intervention and Product Governance Sourcebook (the
"UK Product Governance Requirements"), and/or any equivalent requirements
elsewhere to the extent determined to be applicable, and disclaiming all and
any liability, whether arising in tort, contract or otherwise, which any
"manufacturer" (for the purposes of the UK Product Governance Requirements)
may otherwise have with respect thereto, the New Ordinary Shares have been
subject to a product approval process, which has determined that the New
Ordinary Shares are: (i) compatible with an end target market of retail
investors and investors who meet the criteria of professional clients and
eligible counterparties, each as defined in Chapter 3 of the FCA Handbook
Conduct of Business Sourcebook; and (ii) eligible for distribution through all
permitted distribution channels (the "Target Market Assessment").
Notwithstanding the Target Market Assessment, "distributors" (for the purposes
of the UK Product Governance Requirements) should note that: the price of the
New Ordinary Shares may decline and investors could lose all or part of their
investment; the New Ordinary Shares offer no guaranteed income and no capital
protection; and an investment in the New Ordinary Shares is compatible only
with investors who do not need a guaranteed income or capital protection, who
(either alone or in conjunction with an appropriate financial or other
adviser) are capable of evaluating the merits and risks of such an investment
and who have sufficient resources to be able to bear any losses that may
result therefrom. The Target Market Assessment is without prejudice to any
contractual, legal or regulatory selling restrictions in relation to the
Placing. Furthermore, it is noted that, notwithstanding the Target Market
Assessment, the Joint Global Coordinators will only procure investors who meet
the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute:
(a) an assessment of suitability or appropriateness for the purposes of
Chapters 9A or 10A respectively of the FCA Handbook Conduct of Business
Sourcebook; or (b) a recommendation to any investor or group of investors to
invest in, or purchase, or take any other action whatsoever with respect to
the New Ordinary Shares.

Each distributor is responsible for undertaking its own target market
assessment in respect of the New Ordinary Shares and determining appropriate
distribution channels.

Notice to Canadian Investors

The distribution of Placing Shares in Canada is to be made on a private
placement basis only, exempt from the requirement that the Company prepare and
file a prospectus with the relevant Canadian securities regulatory authorities
and only to those who are both "accredited investors" within the meaning of
National Instrument 45-106 - Prospectus Exemptions (or section 73.3(1) of the
Securities Act (Ontario), as applicable) and "permitted clients" within the
meaning of National Instrument 31-103 - Registration Requirements, Exemptions
and Ongoing Registrant Obligations. In connection with any such sale made to
investors in the Placing that are located in Canada, the Placee will be
required to provide a signed investor qualification statement, confirming its
eligibility to participate in the Placing.

The Company is not a "reporting issuer", as such term is defined under
applicable Canadian securities legislation, in any province or territory of
Canada, its securities are not listed on any stock exchange in Canada and
there is currently no public market for the Placing Shares in Canada. The
Company currently does not intend to file a prospectus or similar document
with any securities regulatory authority in Canada qualifying the resale of
the Placing Shares to the public in any province or territory of Canada or
listing its securities on any stock exchange in Canada. Therefore, there will
be no public market in Canada for the Placing Shares and the resale or
transfer of the Placing Shares will be subject to restrictions. Accordingly,
any resale of the Placing Shares of the Company must be made in accordance
with applicable securities laws, and which may require resales to be made in
accordance with exemptions from registration and prospectus requirements.

Securities legislation in certain provinces or territories of Canada may
provide a purchaser with remedies for rescission or damages if this offering
memorandum (including any amendment thereto) contains a misrepresentation,
provided that the remedies for rescission or damages are exercised by the
purchaser within the time limit prescribed by the securities legislation of
the purchaser's province or territory. The purchaser should refer to any
applicable provisions of the securities legislation of the purchaser's
province or territory for particulars of these rights or consult with a legal
advisor.

The Announcement is not, and under no circumstances is it to be construed as,
an advertisement or a public offering of the Placing Shares in Canada. No
securities commission or similar regulatory authority in Canada has reviewed
or in any way expressed an opinion about the Placing Shares and any
representation to the contrary is an offence.

Forward looking statements

This announcement includes statements that are, or may be deemed to be,
'forward-looking statements'. These forward-looking statements can be
identified by the use of forward-looking terminology, including the terms
'believes', 'estimates', 'plans', 'projects', 'anticipates', 'expects',
'intends', 'may', 'will', or 'should', or, in each case, their negative or
other variations or comparable terminology.

All forward-looking statements address matters that involve risks and
uncertainties. Accordingly, there are or will be important factors that could
cause the Group's actual results to differ materially from those indicated in
these statements. These factors include, but are not limited to, those
described in Appendix III to this announcement. Any forward-looking statements
in this announcement reflect the Company's current views, intentions, beliefs
or expectations with respect to future events and are subject to these and
other risks, uncertainties and assumptions relating to the Group's operations,
results of operations, growth strategy and liquidity.

These forward-looking statements speak only as at the date of this
announcement. Subject to any applicable obligations, the Company undertakes no
obligation to update publicly or review any forward looking statement, whether
as a result of new information, future developments or otherwise. All
subsequent written and oral forward-looking statements attributable to the
Company or individuals acting on behalf of the Company or the Group are
expressly qualified in their entirety by this paragraph. Prospective investors
should specifically consider the factors identified in this announcement which
could cause actual results to differ before making an investment decision.

For the avoidance of doubt, the contents of the Company's website or any
website directly or indirectly linked to the Company's website are not
incorporated by reference into, and do not form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEAEXFEDPSEFA